| Similar Articles |
|---|
 |
Salon.com
August 11, 2000
Andrew O'Hehir |
Stephen King A master of plot mechanics, he revived the moribund genre of horror literature and became the richest writer in history. We could do worse.   |
Salon.com
February 22, 2001
Laura Miller |
"Dreamcatcher" by Stephen King and "Ordinary Horror" by David Searcy King's latest book takes a page from "The X-Files," while an elegantly literary debut tells of creeping, formless suburban terror... |
The Motley Fool
October 31, 2005
Steven Mallas |
Marvel Meets the King Marvel Entertainment and Stephen King hook up for a comic book deal. Marvel shareholders should be excited about this. |
PC Magazine
September 21, 2004 |
Age of Empires II: The Age of Kings The king of real-time strategy games has yet to be dethroned. |
The Motley Fool
May 15, 2007
Brian Lawler |
King Fights for Its Empire King Pharmaceuticals announces another good quarter of financial results. Investors should expect more product acquisitions in the coming years. |
Entrepreneur
June 2007
Geoff Williams |
Name Fame How some entrepreneurs handle sharing their handles. |
Salon.com
October 18, 2001
Laura Miller |
Stephen King, go home! The master of horror should forget hideous other worlds and stick to refrigerator magnets... |
The Motley Fool
October 29, 2004
Bill Mann |
King, Knave, or Village Idiot? Troubled King Pharmaceuticals' latest accounting woes threaten to scuttle its merger with Mylan. |
Pharmaceutical Executive
June 1, 2006
Sara Calabro |
King Without the Crown While most of pharma tries to convince the world that R&D is the number-one priority, one specialty company, King Pharmaceuticals, boasts that it has no lab. |
The Motley Fool
October 5, 2006
Rick Aristotle Munarriz |
The King Wants to Play Burger King believes that Xbox marks the spot of opportunity. The Burger King-branded games will either be marketing genius or a classic blunder. Investors, take note. |
The Motley Fool
September 12, 2008
Brian Lawler |
King's Unstoppable Urge to Merge King Pharmaceuticals announces it has increased its offer to acquire Alpharma, and it is now taking that bid directly to the shareholders. |
Bank Systems & Technology
August 16, 2010
Matt Gunn |
Customer-Centered Banking is the Future, Author Says Brett King discusses his book Bank 2.0 and the future of banking. |
BusinessWeek
July 12, 2004
Roger O. Crockett |
Martin Luther King Jr.: Putting Words To The Dream The American civil rights leader stressed black earning power, never losing sight of the economic underpinnings of his cause. |
Registered Rep.
February 7, 2012
Jerry Gleeson |
Morgan Stanley Smith Barney's King Breaks Away, Taps Dynasty for Help A Morgan Stanley Smith Barney team led by Larry King in Saratoga Springs, N.Y. left the wirehouse and started an independent registered investment advisor, King Wealth Management Group. |
Fast Company
Pavithra Mohan |
Activision To Buy Candy Crush Creator For $5.9 Billion Activision Blizzard, the company behind video games like Call of Duty and World of Warcraft, just inked a deal to acquire King Digital Entertainment, the maker of wildly popular mobile game Candy Crush Saga. |
BusinessWeek
July 22, 2010 |
Hard Choices: Larry King As Larry King Live nears the end of its run, the king of talk remembers his decision to stick with CNN. |
AskMen.com
Kyle Darbyson |
Classic Animal Horror Movies Hollywood has blessed us with plenty of sensational big screen versions of animal attacks. Here are five classics of the genre. |
The Motley Fool
March 3, 2009
Robert Steyer |
Seeking Gain From Pain King Pharmaceuticals tries to remake itself as a pain therapy company. |
Wild West
July 3, 2004
George Gardiner |
Shootout in the Bella Union Hotel Two King Brothers shot it out with rancher Robert Carlisle in a Los Angeles hotel. |
The Motley Fool
March 21, 2011
Jim Royal |
Meet the Cash Kings of Drilling Check out Transocean, the cash king of the drilling sector. |
The Motley Fool
October 12, 2010
Travis Hoium |
King Pharmaceuticals Shares Popped: What You Need to Know King Pharmaceuticals shares are up nearly 40% today after it was announced the company would be purchased by Pfizer Inc. |
The Motley Fool
March 1, 2007
Brian Lawler |
King Atop Its Throne After two quarters of middling revenue growth, drugmaker King Pharmaceuticals reported blowout sales and operating cash flow for its fourth quarter. |
Fast Company
J.J. McCorvey |
Can The King Of Candy Keep Its Throne? More than 500 million have downloaded Candy Crush Saga on their mobile device and brought the smash hit's Dublin-based publisher to the brink of the most anticipated game-industry IPO. |
The Motley Fool
January 30, 2007
Rick Aristotle Munarriz |
The King Gives Investors Bread and Circus If Burger King keeps growing with its franchisees as happy as The King himself, royalties will be even more generous. Investors, take note. |
PC Magazine
July 13, 2004
Matthew D. Sarrel |
WarioWare, Inc.: Mega Party Game$ Move over, beer pong: There's a new king of party games in town. |
The Motley Fool
February 27, 2004
Zeke Ashton |
King Makes a Comeback The love/hate cycle might be ready to shift again for this pharmaceutical. King Pharmaceuticals was once a beloved growth stock. Then it became an unloved drug stock suffering from intensifying competition, a poor acquisition or two, and an ongoing SEC investigation. The stock has started to come back. |
The Motley Fool
February 2, 2006
Rick Aristotle Munarriz |
The King of All IPOs Burger King has a Whopper of an IPO on the grill. Going public may actually help as the fast-food restaurant emerges from the privately held shadows and is held financially accountable against its peers. |
The Motley Fool
May 19, 2005
Steven Mallas |
Kellogg's Royal Partner Kellogg's vegetarian products will be sold at Burger King -- is the beefy Whopper endangered? |
The Motley Fool
July 24, 2007
Lawrence Rothman |
Fool on the Street: Burger King Deposed? Burger King keeps chasing McDonald's, but it has a long way to go to catch up. |
The Motley Fool
April 24, 2006
Bill Mann |
The Ad That Saves Burger King It's not so much that Burger King has struggled to remain competitive in the fast food market, but rather that it's struggled to remain relevant. Here, the author suggests an ad that fixes everything. |
Inc.
January 2009 |
Blogger Logic Cash is king, but the king can't sit idle. |
The Motley Fool
May 28, 2008
Brian Lawler |
King Pays a Modest Ransom King Pharmaceuticals, a prolific acquirer of other companies' drugs, announces that it had painlessly staked its claim to yet another. |
BusinessWeek
April 10, 2006
Dean Foust |
Burger King: Where's The Beef? Burger King's upcoming IPO looks lucrative.. .for the private-equity firms doing the deal. While they make even more cash, the chain's long-term debt could hit $1 billion. |
The Motley Fool
August 27, 2009
Rob Plaza |
Send This Restaurant Stock Back Investors are excited about Burger King, but that likely won't last. |
AskMen.com
Brandon Dyce |
Sean John I AM KING Sean Combs' latest fragrance looks to change all the rules, and I AM KING is sexy, smooth and spot-on. |
BusinessWeek
September 18, 2006
Gene G. Marcial |
Now, Burger King Looks More Appetizing Burger King leaped out of the frying pan into the fire in early August when it reported disappointing results for its fourth quarter ended June 30. |
The Motley Fool
November 13, 2006
Brian Lawler |
King Not Loving Its Shareholders King Pharmaceuticals appears to be a company with stagnating operations, trying to grow sales via licensing or acquiring new drugs, with (at best) a shaky handling of its accounting practices. Investors, take note. |
Financial Planning
August 1, 2009
Jim Grote |
Domestic Affairs Elaine King prepares her divorcee clients for (1) financial independence; (2) a well-planned estate; and (3) a family that is competent and comfortable with wealth. |
Chemistry World
May 13, 2015
Stephen McCarthy |
Venoms to drugs: venom as a source for the development of human therapeutics The book is well-constructed, starting with an overview of the evolutionary origins of venoms and how these relate to common structures, followed by a guide to modern bioinformatics methods and their application to research in this field. |
The Motley Fool
October 26, 2009
Alyce Lomax |
The Scariest Thing About Stephen King's New Book It's not the plot -- it's the price tag. |
The Motley Fool
November 5, 2007
Brian Lawler |
King's Abuse-Resistant Bet King Pharmaceuticals signs a development deal with Acura Pharmaceuticals to produce abuse-resistant painkillers. Investors, take note. |
| AskMen.com |
Nat King Cole: Style Icon Largely opting for dressy attire rather than casual clothing, particularly when performing, Nat King Cole favored suits over all else. |
Fast Company
Rachel Gillett |
Infographic: 6 Rules For Managing Your Business's Facebook Page If you're part of the 93% of marketers who use social media for business, then you already understand how much weight it carries for your company, and you likely place a lot of value in your company Facebook page. |
Bio-IT World
November 19, 2004 |
The Human Stain Using DNA technology to help the victims of human rights abuse. |
The Motley Fool
November 21, 2006
Rick Aristotle Munarriz |
Games Kings Play Burger King wants to play Xbox 360 video games with you this holiday season. So who will get the most out of this relationship, the fast-food restaurant or Microsoft? Investors, take note. |
The Motley Fool
August 25, 2008
Brian Lawler |
King Triples Down King Pharmaceuticals makes a risky all-in bet on an unproven market. |
HBS Working Knowledge
May 3, 2004
Wendy Guild Swearingen |
Can Burger King Rekindle the Sizzle? Burger King's chief marketing officer tells a Harvard Business School audience about a new marketing plan to give the burger giant an image makeover. |
Sports Central
June 5, 2008
Kevin Beane |
Let Joe Paterno Coach What's with the sudden media wave to push Penn State's Joe Paterno out the door? |
